Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome

1 Jul 2013

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Immune Cell Function and Interaction
Share to NF-κB Signaling Pathways

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 23845443
DOI: 10.1016/j.ccr.2013.05.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic SyndromePMID 23845443Read ↗

Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromesSemantic proximity Read ↗

Elevated MLF1 expression correlates with malignant progression from myelodysplastic syndromeSemantic proximity Read ↗

The Role of the Immune System in Myelodysplasia: Implications for TherapySemantic proximity Read ↗

Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemiaSemantic proximity Read ↗

Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155Semantic proximity Read ↗

Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDSSemantic proximity Read ↗

[Targeting Ras related proteins for leukemia therapy].Semantic proximity Read ↗

Ras and myelodysplasia: lessons from the last decade.Semantic proximity Read ↗

U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignanciesSemantic proximity Read ↗

Activation of targetable inflammatory immune signaling is seen in Myelodysplastic Syndromes with SF3B1 mutationsSemantic proximity Read ↗

Lenalidomide: deciphering mechanisms of action in myeloma, myelodysplastic syndrome and beyondSemantic proximity Read ↗

The Ras signaling pathway and the molecular basis of myeloid leukemogenesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.